Home » Topics » Regulatory

Regulatory
RSS

FDA approves new indication, new presentation for atovaquone

Jan. 11, 1999

Ethyol for reducing radiation-induced xerostomia in head and neck cancer filed with FDA

Jan. 8, 1999

FDA approves home use of Lovenox in patients with potentially life-threatening blood clots

Jan. 8, 1999

Mexiletine effectively controls spasmodic torticollis in treatment-refractory patients

Jan. 8, 1999

Interneuron receives milestone payment from Lilly under Prozac agreement

Jan. 7, 1999

FDA approves OTC status for Elan's nicotine patch

Jan. 7, 1999

Proleukin receives orphan drug status for two new indications

Jan. 7, 1999

Levofloxacin cleared for new indication by FDA

Jan. 5, 1999

Important end-of-year approval by FDA: Celebrex for arthritis

Jan. 4, 1999

Expanded use of Photofrin approved by FDA

Jan. 4, 1999

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....